Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FDA
Recent news which mentions FDA
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Spero Therapeutics Shares Jump After Upbeat FDA Feedback For Tebipenem HBr Program
September 06, 2022
Tickers
SPRO
Tags
Health Care
Trading Ideas
Briefs
From
Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
Tags
Benzinga
SRPT
General
From
Benzinga
FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect
September 06, 2022
Tickers
EIGR
Tags
Briefs
Pre/Market Outlook
Health Care
From
Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
September 02, 2022
Tickers
IMRX
NVAX
PYPD
VRTX
Tags
PYPD
Benzinga
Health Care
From
Benzinga
Vertex Pharma's Flagship Cystic Fibrosis Drug Scores FDA Approval For Infants
September 02, 2022
Tickers
VRTX
Tags
Biotech
FDA
Health Care
From
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
Tickers
AXSM
BNTX
HLTH
HOWL
Tags
News
HLTH
FDA
From
Benzinga
FDA Advisory Committee Meeting Scheduled For October 28, 2022 To Review Y-mAbs' Refiling For Omburtamab
September 01, 2022
Tickers
YMAB
Tags
YMAB
FDA
Health Care
From
Benzinga
Intellia Gets FDA Orphan Drug Status For Hereditary Angioedema Candidate
September 01, 2022
Tickers
NTLA
Tags
NTLA
General
Benzinga
From
Benzinga
Amneal Seeks FDA Approval For Its Parkinson's Candidate
September 01, 2022
Tickers
AMRX
Tags
Penny Stocks
Health Care
FDA
From
Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Tickers
AMD
AMZN
BA
BABA
Tags
PFE
MRK
Benzinga
From
Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
September 01, 2022
Tickers
SNY
Tags
Briefs
FDA
Health Care
From
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
AXSM
CRMD
SNY
From
Benzinga
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
August 31, 2022
Tickers
BRTX
NVO
PFE
VRTX
Tags
Market News
VRTX
News
From
Benzinga
Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022
Tickers
LGVN
Tags
Benzinga
General
News
From
Benzinga
Aquestive Gets FDA Tentative Approval For Libervant In Seizure Clusters Management
August 31, 2022
Tickers
AQST
Tags
AQST
General
Benzinga
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today